These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 33557246)

  • 1. Development and Effects of Influenza Antiviral Drugs.
    Yin H; Jiang N; Shi W; Chi X; Liu S; Chen JL; Wang S
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33557246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral Activity of Aspalathus linearis against Human Influenza Virus.
    Rahmasaria R; Haruyama T; Charyasriwong S; Nishida T; Kobayashi N
    Nat Prod Commun; 2017 Apr; 12(4):599-602. PubMed ID: 30520604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspective of Use of Antiviral Peptides against Influenza Virus.
    Skalickova S; Heger Z; Krejcova L; Pekarik V; Bastl K; Janda J; Kostolansky F; Vareckova E; Zitka O; Adam V; Kizek R
    Viruses; 2015 Oct; 7(10):5428-42. PubMed ID: 26492266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyunsaturated fatty acids from Phyllocaulis boraceiensis mucus block the replication of influenza virus.
    de Toledo-Piza AR; de Oliveira MI; Negri G; Mendonça RZ; Figueiredo CA
    Arch Microbiol; 2018 Aug; 200(6):961-970. PubMed ID: 29616305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Influenza Drug Discovery and Development: Targeting the Virus and Its Host by All Possible Means.
    Terrier O; Slama-Schwok A
    Adv Exp Med Biol; 2021; 1322():195-218. PubMed ID: 34258742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza chemotherapy: a review of the present state of art and of new drugs in development.
    Lüscher-Mattli M
    Arch Virol; 2000; 145(11):2233-48. PubMed ID: 11205114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herbal Medicines with Antiviral Activity Against the Influenza Virus, a Systematic Review.
    Lee JY; Abundo MEC; Lee CW
    Am J Chin Med; 2018; 46(8):1663-1700. PubMed ID: 30612461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and mechanisms of anti-influenza virus metabolites isolated from the Vietnamese medicinal plant Polygonum chinense.
    Tran TT; Kim M; Jang Y; Lee HW; Nguyen HT; Nguyen TN; Park HW; Le Dang Q; Kim JC
    BMC Complement Altern Med; 2017 Mar; 17(1):162. PubMed ID: 28327126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral strategies against influenza virus: towards new therapeutic approaches.
    Loregian A; Mercorelli B; Nannetti G; Compagnin C; Palù G
    Cell Mol Life Sci; 2014 Oct; 71(19):3659-83. PubMed ID: 24699705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New drug-strategies to tackle viral-host interactions for the treatment of influenza virus infections.
    van de Wakker SI; Fischer MJE; Oosting RS
    Eur J Pharmacol; 2017 Aug; 809():178-190. PubMed ID: 28533172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress of small molecular inhibitors in the development of anti-influenza virus agents.
    Wu X; Wu X; Sun Q; Zhang C; Yang S; Li L; Jia Z
    Theranostics; 2017; 7(4):826-845. PubMed ID: 28382157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-influenza virus agents: synthesis and mode of action.
    Lagoja IM; De Clercq E
    Med Res Rev; 2008 Jan; 28(1):1-38. PubMed ID: 17160999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza Virus: Small Molecule Therapeutics and Mechanisms of Antiviral Resistance.
    Han J; Perez J; Schafer A; Cheng H; Peet N; Rong L; Manicassamy B
    Curr Med Chem; 2018; 25(38):5115-5127. PubMed ID: 28933281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The preventive and therapeutic potential of natural polyphenols on influenza.
    Bahramsoltani R; Sodagari HR; Farzaei MH; Abdolghaffari AH; Gooshe M; Rezaei N
    Expert Rev Anti Infect Ther; 2016; 14(1):57-80. PubMed ID: 26567957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of influenza virus replication by plant-derived isoquercetin.
    Kim Y; Narayanan S; Chang KO
    Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza virus-host interactomes as a basis for antiviral drug development.
    Watanabe T; Kawaoka Y
    Curr Opin Virol; 2015 Oct; 14():71-8. PubMed ID: 26364134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
    Moorthy NS; Poongavanam V; Pratheepa V
    Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.
    Pizzorno A; Terrier O; Nicolas de Lamballerie C; Julien T; Padey B; Traversier A; Roche M; Hamelin ME; Rhéaume C; Croze S; Escuret V; Poissy J; Lina B; Legras-Lachuer C; Textoris J; Boivin G; Rosa-Calatrava M
    Front Immunol; 2019; 10():60. PubMed ID: 30761132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baloxavir marboxil, a novel cap-dependent endonuclease inhibitor potently suppresses influenza virus replication and represents therapeutic effects in both immunocompetent and immunocompromised mouse models.
    Fukao K; Ando Y; Noshi T; Kitano M; Noda T; Kawai M; Yoshida R; Sato A; Shishido T; Naito A
    PLoS One; 2019; 14(5):e0217307. PubMed ID: 31107922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza viruses: basic biology and potential drug targets.
    Basler CF
    Infect Disord Drug Targets; 2007 Dec; 7(4):282-93. PubMed ID: 18220960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.